Interpretation of arrhythmogenic effects of COVID-19 disease through ECG

We aimed to detect the malignant arrhythmic potential of COVID-19 with surface electrocardiographic (ECG) markers. Of the ECG parameters PR, QT, QTc, QTd, TPe, and Tpe/QTc were measured in 51 COVID-19 patients and 40 in control subjects. Compared to control group mean QTc (410.8 ± 24.3 msec vs. 394....

Full description

Saved in:
Bibliographic Details
Published in:The aging male Vol. 23; no. 5; p. 1362
Main Authors: Öztürk, Fatih, Karaduman, Medeni, Çoldur, Rabia, İncecik, Şaban, Güneş, Yılmaz, Tuncer, Mustafa
Format: Journal Article
Language:English
Published: England 01-12-2020
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We aimed to detect the malignant arrhythmic potential of COVID-19 with surface electrocardiographic (ECG) markers. Of the ECG parameters PR, QT, QTc, QTd, TPe, and Tpe/QTc were measured in 51 COVID-19 patients and 40 in control subjects. Compared to control group mean QTc (410.8 ± 24.3 msec vs. 394.6 ± 20.3 msec,  < .001) and Tpe/QTc (0.19 ± 0.02 vs. 0.18 ± 0.04, = .036) and median QTd (47.52 vs. 46.5) values were significantly higher in COVID-19 patients. Troponin levels were significantly correlated with heart rate (  = 0.387,  = .006) but not with ECG parameters. Several ventricular arrhythmia surface ECG predictors including QTc, QTd, and Tpe/QTc are increased in COVID-19 patients. Since medications used in COVID-19 patients have the potential to affect these parameters, giving importance to these ECG markers may have a significant contribution in decreasing disease-related arrhythmias.
ISSN:1473-0790
DOI:10.1080/13685538.2020.1769058